Projects and publications

Recent publications

May 21, 2019: Stop. Putting. CBD. In. Everything.

April 30, 2019: Cannabidiol: manufacturer claims the cannabis derivative has ‘no real side effects’

March 29, 2019: Patients suffering in cannabis roadblocks

March 14, 2019: Patient access to medical cannabis in Australia

Feb 23, 2019: Desperate patients turn to black market for medicinal cannabis despite spike in legal prescriptions

August 6, 2018: Clearing the air: A response on medical cannabis

July 4, 2018: GPs call for education on medicinal cannabis

June 21, 2018: Patient flies to Canada over “serious failure” in medicinal cannabis approval

November 20, 2017: States blocking up to 20% of Federally-approved medicinal cannabis patients

November 1, 2017: Medicinal cannabis

July 25, 2017: Will cannabis be Australia’s next growth engine?

June 14, 2017: Making sense of recent changes in medicinal cannabis laws in Australia

May 30, 2017: Medicinal Cannabis Leadership Program officially launched at Victoria Parliament House

May 19, 2017: Australia needs a medicinal cannabis industry

March 22, 2017: Three ways Australian cannabis will change in 2017

March 16, 2017: Pot stocks don’t help people, cannabis companies do

Other relevant publications

October 13, 2017: The cannabis oil ‘healers’ preying on Australia’s sick and dying

June 15, 2017: Growing cannabis industry buoyed by regulation change

June 15, 2017: Doctors on a downer over medicinal cannabis imports

May 20, 2017: Australia’s first medicinal cannabis course to teach students ‘whole continuum’ of plant

May 2, 2017: Curb your enthusiasm: The overhyped medicinal cannabis ‘pot stock’ boom

November 3, 2016: Australia’s MMJ market likely to develop slowly, with big players dominating

Major projects

CCA staff have completed two projects for the University of Sydney, on behalf of their client mgcPharma.

Development of a white paper outlining the Australian cannabis regulatory environment and potential markets.  You can download the white paper here:


Development of a report summarising the clinical evidence supporting the use of medical cannabis in the treatment of epilepsy, cancer and multiple sclerosis.  You can download the report here:


We have also published a summary which sets out the decisions you’ll need to make before you can apply for a Federal cannabis licence, and also summarises the information you’ll have to include in your application. You can download that summary here:

We have developed a short paper summarising the treatment of pain with medicinal cannabis in Australia, in association with Pain Australia, which you can download here: